Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarperin vs dexamethasone for prevention of radiation-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR2200064576Phase 3Recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 3, randomised trial of sarperin in stomatitis and nasopharyngeal carcinoma (NPC) (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoints: Incidence of radiation-induced oral mucositis and Oral cavity mucous membrane. Started Oct 2022; status: recruiting.
02
Drugs
sarperin
03
Conditions
stomatitisnasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR2200064576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064576.